870194.fig.002
Figure 2: Relative area (means ± SD) of the PCM darker pixels in 5 psoriatic lesions from 5 patients (A to E) at inclusion and after a 1-month ustekinumab treatment. The global reduction in high capacitance inflammatory areas is significant ( 𝑃 < 0 . 0 1 ).